Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 12/2015

01-12-2015 | Letter to the Editor

Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma: a Letter to Response

Authors: Wei Liu, Jian-Guo Zhou, Bao-Cai Xing

Published in: Journal of Gastrointestinal Surgery | Issue 12/2015

Login to get access

Excerpt

As a general principle, it is essential to generate, summarize, and understand the best available evidence in order to establish the effects and safety of interventions. Meta-analysis has become a valuable tool toward these ends,1 an approach that can play a critical role in generating guidelines and treatment recommendations to appropriate patients. Evidence-based medicine is the concept of treating patients according to the best available evidence of guidelines. This approach still can integrate all of the relevant evidence and provide a more reliable answer than any single study, however well conducted.1 Our meta-analysis enrolled eight retrospective studies with results were highly concordant. Although not ideal, it is still appropriate to conduct a meta-analysis with this information, and we discussed the limitations in evidence level in our manuscript.2
Literature
1.
go back to reference Berlin J A, Golub R M. Meta-analysis as evidence: building a better pyramid[J]. JAMA,2014,312(6):603–605.CrossRefPubMed Berlin J A, Golub R M. Meta-analysis as evidence: building a better pyramid[J]. JAMA,2014,312(6):603–605.CrossRefPubMed
2.
go back to reference Bakhsheshian J, Hwang M S, Friedman M. Association Between Obstructive Sleep Apnea and Spontaneous Cerebrospinal Fluid Leaks: A Systematic Review and Meta-analysis[J]. JAMA Otolaryngol Head Neck Surg,2015,141(8):733–738.CrossRefPubMed Bakhsheshian J, Hwang M S, Friedman M. Association Between Obstructive Sleep Apnea and Spontaneous Cerebrospinal Fluid Leaks: A Systematic Review and Meta-analysis[J]. JAMA Otolaryngol Head Neck Surg,2015,141(8):733–738.CrossRefPubMed
3.
go back to reference Bolondi L, Burroughs A, Dufour J F, et al. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions[J]. Semin Liver Dis,2012,32(4):348–359.PubMed Bolondi L, Burroughs A, Dufour J F, et al. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions[J]. Semin Liver Dis,2012,32(4):348–359.PubMed
5.
go back to reference Ciria R, Lopez-Cillero P, Gallardo A B, et al. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization[J]. Eur J Surg Oncol,2015,41(9):1153–1161.CrossRefPubMed Ciria R, Lopez-Cillero P, Gallardo A B, et al. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization[J]. Eur J Surg Oncol,2015,41(9):1153–1161.CrossRefPubMed
6.
go back to reference Zhong J H, Ke Y, Gong W F, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg,2014,260(2):329–340.CrossRefPubMed Zhong J H, Ke Y, Gong W F, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg,2014,260(2):329–340.CrossRefPubMed
7.
go back to reference Zhu S L, Ke Y, Peng Y C, et al. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis[J]. PLoS One,2014,9(12):e115834.PubMedCentralCrossRefPubMed Zhu S L, Ke Y, Peng Y C, et al. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis[J]. PLoS One,2014,9(12):e115834.PubMedCentralCrossRefPubMed
8.
go back to reference Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments[J]. Cancer,1996,77(10):2022–2031.CrossRefPubMed Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments[J]. Cancer,1996,77(10):2022–2031.CrossRefPubMed
9.
go back to reference Shah S A, Greig P D, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes[J]. J Am Coll Surg,2006,202(2):275–283.CrossRefPubMed Shah S A, Greig P D, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes[J]. J Am Coll Surg,2006,202(2):275–283.CrossRefPubMed
10.
go back to reference Li L, Wang H. Heterogeneity of liver cancer and personalized therapy[J]. Cancer Lett,2015. Li L, Wang H. Heterogeneity of liver cancer and personalized therapy[J]. Cancer Lett,2015.
11.
go back to reference Heng-Jun G, Yao-Jun Z, Min-Shan C, et al. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma[J]. Liver Int,2014,34(4):612–620.CrossRefPubMed Heng-Jun G, Yao-Jun Z, Min-Shan C, et al. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma[J]. Liver Int,2014,34(4):612–620.CrossRefPubMed
12.
go back to reference Yin L, Li H, Li A J, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT[J]. J Hepatol,2014,61(1):82–88.CrossRefPubMed Yin L, Li H, Li A J, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT[J]. J Hepatol,2014,61(1):82–88.CrossRefPubMed
13.
go back to reference Lin C T, Hsu K F, Chen T W, et al. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?[J]. World J Surg,2010,34(9):2155–2161.CrossRefPubMed Lin C T, Hsu K F, Chen T W, et al. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?[J]. World J Surg,2010,34(9):2155–2161.CrossRefPubMed
14.
go back to reference Zhong J H, Xiang B D, Gong W F, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PLoS One,2013,8(7):e68193.PubMedCentralCrossRefPubMed Zhong J H, Xiang B D, Gong W F, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PLoS One,2013,8(7):e68193.PubMedCentralCrossRefPubMed
15.
Metadata
Title
Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma: a Letter to Response
Authors
Wei Liu
Jian-Guo Zhou
Bao-Cai Xing
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 12/2015
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2966-1

Other articles of this Issue 12/2015

Journal of Gastrointestinal Surgery 12/2015 Go to the issue